Overcoming the problem of cytomegalovirus infection after organ transplantation: Calling for heracles?

Intervirology

Volumn 42, Issue 5-6, 1999, Pages 285-290

  Van Son, Willem J ^a   De Maar, Eltjo F ^b   Van Der Bij, Wim ^b   Van Den Berg, Arie P ^b   Verschuuren, Erik A M ^b   The, T Hauw ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Cytomegalovirus infection; Organ transplantation; Pathophysiology; Symptomatology

Indexed keywords

ANTIVIRUS AGENT;

CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; HUMAN; INFECTION RISK; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYMPTOMATOLOGY;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0343114301     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053962     Document Type: Conference Paper

References (61)

1. Lautenschlager I: Role of cytomegalovirus infection in the processes of organ allograft rejection; in Scholz M, Rabenau HF, Doerr HW, Cinatl J (eds): CMV-Related Immunopathology. Monogr Virol. Basel, Karger 1998, vol 21, pp 142-157.
2. Grattan MT, Moreno Cabral CE, Starnes VA, Over PE, Stinson EB, Shumway NE: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561-3566.
3. Koskinen PK, Kallio EA, Tikkanen JM, Shivola RK, Hayry PJ, Lemstrom KB: Cytomegalovirus infection and cardiac allograft vasculopathy (review article). Transplant Infect Dis 1999;1:115-126.
4. Rubin RH: Infection in the organ transplant recipient; in Rubin RH, Young LS (eds): Clinical approach to infection in the compromised host, ed 3. New York, Plenum Press, 1994, pp 629-705.
5. Bruning JH, Bruggeman CA, Van Boven CP, Van Breda-Vriesman PJ: Reactivation of latent rat cytomegalovirus by combination of immunosuppression and administration of allogeneic immunocompetent cells. Transplantation 1989;47:917-918.
6. Stein J, Volk HD, Liebenthal C, Kruger DH, Frosch S: Tumor necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J Gen Virol 1993; 74:2333-2338.
7. Docke WD, Frosch S, Fietze E, Kimel V, Zuckermann H, Klug C, Syrbe U, Kruger DH, Von Baehr R, Volk HD: Cytomegalovirus reactivation and tumor necrosis factors. Lancet 1994; 343:268-269.
8. Prosch S, Volk HD, Reinke P, Pioch K, Docke WD, Kruger DH: Human cytomegalovirus infection in transplant recipients: Role of TNF-α for reactivation and replication of human cytomegalovirus; in Scholz M, Rabenau HF, Doerr HW, Cinatl J (eds): CMV-Related Immunopathology. Monogr Virol. Basel, Karger, 1998, vol 21, pp 29-41.
9. Van Son WJ, The TH: Cytomegalovirus infection alter organ transplantation: An update with special emphasis on renal transplantation. Transplant Int 1989;2:147-164.
10. Van den Berg AP, van der Bij W, Van Son WJ, Anema J, Van der Giessen M, Schirm J, Tegzess AM, The TH: Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation: A report of 130 consecutive patients. Transplantation 1989;48:991-995.
11. Cope AV, Sweny P, Sabin C, Rees L, Griffiths PD, Emery VC: Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J Med Virol 1997;52:200-205.
12. Cope AV, Sabin C, Burroughs A, Rolles K, Griffiths PD, Emery VC: Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J Infect Dis 1997;176: 1484-1490.
13. Hassan-Walker AF, Kidd IM, Sabin C, Sweny P, Griffiths PD, Emery VC: Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor in renal allograft recipients: Relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin. J Med Virol 1999;58:182-187.
14. Fryd DS, Peterson PK, Ferguson RM, Simmons RL, Balfour HH, Najarian JS: Cytomegalovirus as a risk factor in renal transplantation. Transplantation 1980;30:436-439.
15. Rubin RH, Tolkoff-Rubin NE, Oliver D, Rota TR, Hamilton J, Betts RF, Paas RF, Hillis W, Szmuness W, Farell ML, Hirsch MS: Multi-center seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 1985;40:243-249.
16. Bia MJ, Andiman W, Gaudio K, Kliger A, Siegel N, Smith D, Flye W: Effect of treatment with cyclosporine versus azathioprine on incidence and severity of cytomegalovirus infection posttransplantation. Transplantation 1985;40:610-614.
17. Lewis RM, Johnson PC, Golden D, van Buren CT, Kerman RH, Kahan BD: The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporin-prednisolone treated renal allograft recipients. Transplantation 1988;45:353-359.
18. Schnitzler MA, Woodward RS, Brennan DC, Spitznagel EL, Dunagan WC, Baily TC: Impact of cytomegalovirus serology on graft survival in living related kidney transplantation: Implications for donor selection. Surgery 1997;121: 563-568.
19. George MJ, Snydman DR, Werner BG, Griffith J, Falagas ME, Dougherty NN, Rubin RH: The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Am J Med 1997;103:106-113.
20. Schnitzler MA, Woodward RS, Brennan DC, Phelan DL, Spitznagel EL, Boxerman SB, Dunagan WC, Baily TC: Cytomegalovirus and HLA-A, B, and Dr locus interactions: Impact on renal transplant survival. Am J Kidney Dis 1997;30:766-771.
21. Bock GH, Sullivan EK, Miller D, Gimon D, Alexander S, Ellis E, Elshihabi I: Cytomegalovirus infection following renal transplantation - effects on antiviral prophylaxis: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1997;11:665-671.
22. Rosen HR, Corless CL, Rabkin J, Chou S: Association of cytomegalovirus genotype with graft rejection after liver transplantation. Transplantation 1998;66:1627-1631.
23. Ayulo M, Aisner SC, Margolis K, Moravec C: Cytomegalovirus-associatcd gastritis in a compromised host. JAMA 1980;243:1364.
24. Foucar E, Mukai KM, Foucar K, Sutherland DER, van Buren CT: Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol 1981;76:788-801.
25. Cohen EB, Komorowski RA, Kaufman HM, Adams M: Unexpectedly high incidence of cytomegalovirus infection in apparent peptid ulcers in renal transplant patients. Surgery 1985; 97:606-612.
26. Shrestha BM, Parton D, Gray A, Shepard D, Griffith D, Westmoreland D, Griffin P, Lord R, Salaman JR, Moore RH: Cytomegalovirus involving gastrointestinal tract in renal transplant recipients. Clin Transplant 1996;10:170-175.
27. Toogood GJ, Gillespie PH, Gujral S, Warren BF, Roake JA, Gray DW, Morris PJ: Cytomegalovirus infection and colonic perforation in renal transplant patients. Transplant Int 1996; 9:248-251.
28. Halme L, Hockerstedt K, Salmela K, Lautenschlager I: CMV infection detected in the upper gastrointestinal tract after liver transplantation. Transplant Int 1998;11(suppl 1): S242-244.
29. Golden MP, Hammer SM, Wanke CA, Albrecht MA: Cytomegalovirus vasculitis. Case report and review of the literature. Medicine (Baltimore) 1994;73:246-255.
30. Clarke J, Craig RM, Saffro R, Murphy P, Yokoo H: Cytomegalovirus granulomatous hepatitis. Am J Med 1979;66:264-269.
31. van Son WJ, van der Jagt EJ, van der Woude FJ, Slooff MJH, Meijer S, The TH, Tegzess AM, van der Slikke LB, Donker AJM: Pneumatosis intestinalis in patients after cadaveric kidney transplantation: Possible relationship with an active CMV infection. Transplantation 1984;38:506-510.
32. Mannes GP, De Boer WJ, van der Jagt EJ, Meinesz AF, Meuzelaar JJ, van der Bij W: Pneumatosis intestinalis and active cytomegaloviral infection after lung transplantation. Groningen Lung Transplant Group. Chest 1994;105:929-930.
33. Franzin G, Muolo A, Griminelli T: Cytomegalovirus inclusion bodies in the gastroduodenal mucosa of patients after renal transplantation. Gut 1981;22:698-701.
34. Dorfman LJ: Cytomegalovirus encephalitis in adults. Neurology 1973;23:136-144.
35. Minars N, Silverman JF, Escobar MR, Martinez AJ: Fatal cytomegalic inclusion disease. Arch Dermatol 1997;113:1569-1571.
36. Hart IK, Kennedy PGE: Guillain-Barré syndrome associated with cytomegalovirus infection. Q J Med (New Ser 67) 1988;253:425-430.
37. Yu RK, Ariga T, Kohriyama T, Kusunoki S, Maeda Y, Miyatani N: Autoimmune mechanism in peripheral neuropathies. Ann Neurol 1990;27(suppl):S30-305.
38. Wucherpfennig KW, Strominger JL: Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80: 695-705.
39. de Maar EF, Kas-Deelen DM, de Jager AE, The H, Tegzess AM, van Son WJ: Inflammatory demyelinating polyneuropathy in a kidney transplant patient with cytomegalovirus infection. Nephrol Dial Transplant 1999;14:2228-2230.
40. Peterson PK, Balfour HH, Marker SC, Fryd DS. Howard RJ, Simmons RL: Cytomegalovirus-disease in renal allograft recipients: A prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine 1980;59:283-300.
41. Von Willebrand E, Petterson E, Ahonen J, Hayry P: CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986;42:364-367.
42. Funjinami RS, Nelson JA, Walker L, Oldstone MBA: Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR β chain: A means for graft rejection and immunosuppression. J Virol 1988;62: 100-105.
43. Reinke P, Fietze E, Ode-Hakim S, Prosch S, Lippert J, Ewert R, Volk HD: Late acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994;344:1737-1738.
44. Richardson WP, Colvin RB, Cheeseman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB, Collins AB, Hirsch MS, Mcluskey RT, Russel PS, Rubin RH: Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 1981;305:57-63.
45. Herrera GA, Alexander RW, Cooley CF, Luke RG, Kelly DR, Curtis JJ, Gockerman JP: Cytomegalovirus glomerulopathy: A controversial lesion. Kidney Int 1986;29:725-733.
46. Boyce NW, Hayes K, Ge D, Holdsworth SR, Thomson NM, Scott D, Atkins RC: Cytomegalovirus infection complicating renal transplantation and its relationship to acute transplant glomerulopathy. Transplantation 1988;45: 706-709.
47. Husni RN, Gordon SM, Longworth DL, Arroliga A, Stillwell PC, Avery RK, Maurer JR, Metha A, Kirby T: Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998;26: 753-755.
48. George MJ, Snydman DR, Werner BG, Griffith J, Falagas ME, Dougherty NN, Rubin RH: The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc Gaithersburg, Maryland. Am J Med 1997;103:106-113.
49. van der Bij W, Torensma R, van Son WJ, Anema J, Schirm J, Tegzess AM, The TH: Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. J Med Virol 1988;25:179-188.
50. Grundy JE, Shanley JD, Griffiths PD: Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet 1987;ii:996-999.
51. Persoons MCJ, Stals FS, van Dam-Mieras MC, Bruggeman CA: Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. J Pathol 1998;184:103-109.
52. Span AHM, van Boven CPA, Bruggeman CA: The effect of cytomegalovirus infection on the adherence of polymorphonuclear leukocytes to endothelial cells. Eur J Clin Invest 1989;19: 542-548.
53. van Dam-Mieras MCE, Muller AD, van Hinsberg VWM, Mullers WJHA, Bomans PHH, Bruggeman CA: The procoagulant response of cytomegalovirus infected endothelial cells, Thromb Haemost 1992;68:364-370.
54. Almeida GD, Porada CD, St Jeor S, Ascensao JI: Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 1994; 83:370-376.
55. Grefte JMM, van der Giessen M, van Son WJ, The TH: Circulating human cytomegalovirus (HCMV)-infected endothelial cells in patients with an active HCMV infection. J Infect Dis 1993;167:270-277.
56. Grefte JMM, Blom N, van der Giessen M, van Son WJ, The TH: Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: Evidence for virus production and endothelial origin. J Infect Dis 1993;168:1110-1118.
57. van Son WJ, Tegzess AM, The TH, Duipmans J, Slooff MJH, van der Mark TW, Peset R: Pulmonary dysfunction is common during a CMV infection after renal transplantation, even in asymptomatic patients: Possible relationship with complement activation. Am Rev Respir Dis 1987;136:580-585.
58. van Son WJ, van der Bij W, Tegzess AM, Anema J, van der Giessen M, van der Hem GK, Marrink JM, The TH: Complement activation during active cytomegalovirus infection after renal transplantation: Due to circulating immune complexes or alternate pathway activation? Clin Immunol Immunopathol 1989;50: 109-121.
59. de Maar EF, Kas-Deelen AM, The TH, Tegzess AM, Ploeg RJ, van Son WJ: Cytomegalovirus pneumonitis after kidney transplantation is not caused by plugging of cytomegalic endothelial cells alone. Transpl Int 1999;12:56-62.
60. Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG: Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect Immun 1998;66:912-922.
61. de Maar EF, Kleibeuker JH, Boersma-van Ek W, The TH, van Son WJ: Increased intestinal permeability during CMV infections in renal transplant recipients. Transplant Int 1996;9: 576-580.